Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iterum Therapeutics Plc

0.9909
-0.0052-0.52%
Post-market: 0.9900-0.0009-0.09%19:41 EDT
Volume:459.50K
Turnover:455.84K
Market Cap:39.64M
PE:-1.07
High:1.02
Open:0.9800
Low:0.9701
Close:0.9961
Loading ...

Iterum Therapeutics Signs Agreement with Eversana for U.S. Commercialization of ORLYNVAHTM

Reuters
·
11 Jun

Iterum Therapeutics announces partnership for commercialization services

TIPRANKS
·
11 Jun

Iterum Therapeutics Announces Partnership for Commercialization Services

THOMSON REUTERS
·
11 Jun

Iterum Therapeutics Plc - Enters Commercialization Agreement With Eversana for Orlynvah

THOMSON REUTERS
·
11 Jun

Iterum Therapeutics Announces Extension and Increased Interest Rate on Promissory Note with Pfizer

Reuters
·
19 May

Iterum Therapeutics Plc - Pfizer Extends $20 Mln Milestone Payment Term to October 2029

THOMSON REUTERS
·
19 May

Iterum Therapeutics Announces Extension of Term of Promissory Note

THOMSON REUTERS
·
19 May

Press Release: Iterum Therapeutics Announces Extension of Term of Promissory Note

Dow Jones
·
19 May

BRIEF-Iterum Therapeutics PLC Preparing For Potential Launch Of Orlynvah(Tm) By Q4 2025

Reuters
·
13 May

Iterum Therapeutics Reports Q1 2025 Financial Results with Non-GAAP Net Loss Adjustments; Prepares for ORLYNVAHTM Launch by Q4 2025

Reuters
·
13 May

Iterum Therapeutics Plc: Extended Cash Runway Into 2026

THOMSON REUTERS
·
13 May

Iterum Therapeutics Plc: Preparing for Potential Launch of Orlynvah(Tm) by Q4 2025

THOMSON REUTERS
·
13 May

Iterum Therapeutics PLC expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
09 May

Iterum Therapeutics Plc : H.c. Wainwright Assumes Coverage With Buy Rating; Price Target $9

THOMSON REUTERS
·
08 May

BRIEF-Iterum Therapeutics Announces $5 Million Registered Direct Offering Of Ordinary Shares

Reuters
·
29 Apr

Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares

THOMSON REUTERS
·
29 Apr

Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares

GlobeNewswire
·
29 Apr

Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics

GlobeNewswire
·
14 Apr

Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ...

GuruFocus.com
·
08 Feb

Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH™ Despite FDA Approval

TIPRANKS
·
08 Feb